Literature DB >> 3922532

Platelet immune complex interaction in pathogenesis of Kawasaki disease and childhood polyarteritis.

M Levin, P C Holland, T J Nokes, V Novelli, M Mola, R J Levinsky, M J Dillon, T M Barratt, W C Marshall.   

Abstract

The role of platelets in the pathogenesis of vasculitis and the formation of coronary artery aneurysms was studied in 19 children with Kawasaki disease and five with polyarteritis. All patients with Kawasaki disease developed thrombocytosis in the third week of illness. The peak platelet count was significantly correlated (p less than 0.005) with the subsequent development of coronary artery aneurysms. The rise in platelet count was associated with the appearance in the circulation of a factor that induced aggregation and serotonin release in normal platelets. This factor was shown to be of high molecular weight, and its activity was lost at low pH--features suggestive of an immune complex. Immune complexes, detected by precipitation with polyethylene glycol, also appeared in the circulation as the platelet count increased. These complexes induced platelet aggregation, and there was a significant correlation (p less than 0.001) between the concentrations of IgG and IgA in the polyethylene glycol precipitated material and the platelet aggregating activity. Similar platelet aggregating activity was also detected in patients with polyarteritis but followed a different time course, persisting in the circulation for several months in association with continued disease activity. These findings imply that different mechanisms have a role in distinct phases of Kawasaki disease. The initial feverish phase (probably infective) is probably followed by an immune complex vasculitis that occurs when antibodies to the initiating agent appear in the circulation. The immune complexes aggregate platelets and induce release of serotonin. Platelet derived vasoactive mediators may increase vascular permeability and facilitate further deposition of complexes in the tissues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3922532      PMCID: PMC1415706          DOI: 10.1136/bmj.290.6480.1456

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  24 in total

1.  Kawasaki disease (acute febrile infantile muco-cutaneous lymph node syndrome) in Japan; relationship with infantile periarteritis nodosa.

Authors:  N Tanaka
Journal:  Pathol Microbiol (Basel)       Date:  1975

2.  IN VITRO DAMAGE OF RABBIT PLATELETS BY AN UNRELATED ANTIGEN-ANTIBODY REACTION. I. GENERAL CHARACTERISTICS OF THE REACTION.

Authors:  D J GOCKE; A G OSLER
Journal:  J Immunol       Date:  1965-02       Impact factor: 5.422

3.  Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome.

Authors:  S Kusakawa; D C Heiner
Journal:  Pediatr Res       Date:  1976-02       Impact factor: 3.756

4.  Rickettsia-like bodies in infantile acute febrile mucocutaneous lymph-node syndrome.

Authors:  Y Hamashima; K Kishi; K Tasaka
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

5.  Saturation of the reticuloendothelial system with soluble immune complexes.

Authors:  A O Haakenstad; M Mannik
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

6.  Interaction in human blood platelets, viruses and antibodies. I. Platelet aggregation test with microequipment.

Authors:  K Penttinen; G Myllylä
Journal:  Ann Med Exp Biol Fenn       Date:  1968

7.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome.

Authors:  H Kato; S Koike; M Yamamoto; Y Ito; E Yano
Journal:  J Pediatr       Date:  1975-06       Impact factor: 4.406

8.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

9.  Are infantile periarteritis nodosa with coronary artery involvement and fatal mucocutaneous lymph node syndrome the same? Comparison of 20 patients from North America with patients from Hawaii and Japan.

Authors:  B H Landing; E J Larson
Journal:  Pediatrics       Date:  1977-05       Impact factor: 7.124

10.  Mucocutaneous lymph-node syndrome (Kawasaki disease): probable soluble-complex disorder.

Authors:  C Fossard; R A Thompson
Journal:  Br Med J       Date:  1977-04-02
View more
  16 in total

Review 1.  Innate immune cells in the pathogenesis of primary systemic vasculitis.

Authors:  Durga Prasanna Misra; Vikas Agarwal
Journal:  Rheumatol Int       Date:  2015-09-24       Impact factor: 2.631

Review 2.  Kawasaki disease: recent advances.

Authors:  M Levin; E J Tizard; M J Dillon
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

Review 3.  The aetiology and pathogenesis of major systemic vasculitides.

Authors:  C O Savage; Y C Ng
Journal:  Postgrad Med J       Date:  1986-07       Impact factor: 2.401

4.  Aneurysm of the rabbit common carotid artery induced by periarterial application of calcium chloride in vivo.

Authors:  S D Gertz; A Kurgan; D Eisenberg
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Haemolytic uraemic syndrome and the Thomsen Friedenreich antigen.

Authors:  M E McGraw; M Lendon; R F Stevens; R J Postlethwaite; C M Taylor
Journal:  Pediatr Nephrol       Date:  1989-04       Impact factor: 3.714

6.  Clinical aspects of 100 patients with Kawasaki disease.

Authors:  E J Tizard; A Suzuki; M Levin; M J Dillon
Journal:  Arch Dis Child       Date:  1991-02       Impact factor: 3.791

7.  Kawasaki disease: monitoring of circulating immune complexes.

Authors:  E Salo; R Kekomäki; P Pelkonen; O Ruuskanen; M Viander; O Wagner
Journal:  Eur J Pediatr       Date:  1988-05       Impact factor: 3.183

Review 8.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

Review 9.  Vasculitis from the pediatric perspective.

Authors:  P A Brogan; M J Dillon
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.686

Review 10.  Medium-size-vessel vasculitis.

Authors:  Michael J Dillon; Despina Eleftheriou; Paul A Brogan
Journal:  Pediatr Nephrol       Date:  2009-11-28       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.